Medication info
Yushita Tablets 50 mg (Sitagliptin Hydrochloride Hydrate)

Yushita Tablets 50 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›56.7mg / 1 tablet
Manufacturer / importer
YuYoung Pharmaceutical Co., Ltd.
Appearance
Bright apricot-colored, round, double-convex film-coated tablets
Packaging
28 tablets/box [14 tablets/PTP x 2]
Approval status
Active

MFDS item code 202101746 · Approved 2021.02.22 · Insurance code 648204600

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken regardless of meals. When administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because the dose must be adjusted according to renal function, assessment of renal function is recommended before and periodically after starting this medication. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
YuYoung Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in controlling blood glucose in patients with type 2 diabetes
View approved original text

This medication is used to assist in the improvement of blood glucose control in patients with type 2 diabetes, in conjunction with dietary therapy and exercise therapy. It can be administered alone, but if previous diabetes medication experience is absent and blood glucose control is difficult with monotherapy, it can be used in combination with metformin. Furthermore, when sufficient blood glucose control is not achievable with monotherapy or in combination with sulfonylureas, metformin, thiazolidinediones, or insulin, this medication can be added to enhance treatment effects. Thus, it effectively improves blood glucose control in type 2 diabetes when used alongside various pharmacotherapy.

How to take

Adult dose

Administer 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medication may be taken regardless of meals. When administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because the dose must be adjusted according to renal function, assessment of renal function is recommended before and periodically after starting this medication. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered regardless of the timing of dialysis.

Precautions

This medication can rarely cause serious allergic reactions, so if symptoms such as skin rash, hives, or difficulty breathing occur after administration, use should be discontinued immediately and medical advice should be sought. This medication may cause inflammation of the pancreas; therefore, if symptoms such as abdominal pain, vomiting, or persistent nausea occur, consult a physician immediately. Patients with type 1 diabetes or diabetic ketoacidosis should not use this medication, and it should also not be administered if there is an allergy to this medication or its components. Patients with decreased kidney function need dosage adjustments; therefore, regular kidney function tests should be conducted during treatment. Symptoms of hypoglycemia may appear while taking this medication; thus, particularly when used alongside insulin or sulfonylureas, frequent monitoring of blood glucose levels and precautions against hypoglycemia are advised. This medication can rarely cause side effects such as joint pain or blistering skin disorders; therefore, if severe joint pain or blisters appear on the skin, inform a physician immediately. Women who are pregnant or breastfeeding are advised not to take this medication, and safety and efficacy have not been established in children and adolescents under 18 years of age. In the event of overdosing, the medication should be removed from the gastrointestinal tract and appropriate monitoring, such as ECG tests, should be done; some medications may be removed by hemodialysis if necessary. This medication has relatively low drug interactions when used in combination with other diabetes treatments, but dosage adjustments might be necessary if taken with certain medications; consultation with a physician is recommended. Older adults may have decreased kidney function, so it is essential to assess kidney function before administration and adjust the dose accordingly.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 31 more
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • vesicular pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • dyspepsia
  • dizziness
  • elevated liver enzymes
  • acute renal failure
  • skin rash
  • urticaria
  • cutaneous vasculitis
  • increased blood triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air and kept at room temperature between 1 to 30 degrees Celsius. This way, the medication's efficacy can be maintained and deterioration can be prevented.

Appearance and packaging

Appearance

Bright apricot-colored, round, double-convex film-coated tablets

Package unit

28 tablets/box [14 tablets/PTP x 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.